When every day counts in bringing life-changing therapies to market, Celerion delivers the fastest study start-ups in the industry. Our comprehensive Phase I and clinical pharmacology services eliminate bottlenecks that delay your critical go/no-go decisions.
Industry's fastest start-up times mean your studies begin weeks sooner, accelerating your entire development timeline and competitive advantage.
With 650+ beds across our worldwide network, we offer the capacity to handle your largest studies while maintaining the agility of a dedicated partner. One contract, one contact, zero complications.
Our extensive team of scientists and clinicians brings 50 years of proven expertise to every study, reducing risk and maximizing the value of your investment.
Advanced processes and top-tier project management ensure seamless execution, real-time visibility, and data integrity you can trust. Don't let slow start-ups delay your breakthrough therapy. Partner with the clinical research organization that moves at the speed of innovation.
Celerion 2026. All Rights Reserved. Privacy & Legal